Here's Why HCA Healthcare (HCA) is a Strong Growth Stock

Zacks Investment Research highlights HCA Healthcare (HCA) as a potentially strong growth stock, citing its Growth Style Score of A and a VGM Score of A. The company, the largest non-governmental operator of acute care hospitals in the U.S., is expected to see year-over-year earnings growth of 15.1% for the current fiscal year, with the consensus estimate for fiscal 2025 increasing $0.36 to $25.28 per share following upward revisions by nine analysts in the last 60 days.

Analysis

HCA Healthcare (HCA), the largest non-governmental operator of acute care hospitals in the United States with 190 hospitals and approximately 2,400 ambulatory sites of care as of the end of 2024, displays compelling growth characteristics despite its Zacks Rank of #3 (Hold). The company has earned an 'A' for both its VGM Score and its Growth Style Score, indicating strong potential across value, growth, and momentum factors. Specifically, HCA is forecasting significant year-over-year earnings growth of 15.1% for the current fiscal year. This positive outlook is further supported by recent analyst activity, where nine analysts revised their earnings estimates higher for fiscal 2025 over the last 60 days, resulting in the Zacks Consensus Estimate increasing by $0.36 to $25.28 per share. Additionally, HCA has a track record of exceeding expectations, evidenced by an average earnings surprise of 7.1%. These metrics suggest that while currently rated as a 'Hold', HCA's fundamental growth prospects are robust and are being recognized by analysts.

Key Decisions for Investors

• Investors seeking growth exposure should consider HCA Healthcare based on its projected 15.1% earnings growth for the current fiscal year and positive analyst revisions for fiscal 2025, despite its #3 (Hold) Zacks Rank.
• The strong 'A' ratings for both Growth and VGM Style Scores suggest underlying fundamental strength which may warrant placing HCA on a shortlist, particularly if the factors contributing to the 'Hold' rating are perceived as temporary or manageable.
• It is prudent to monitor HCA's upcoming earnings reports and any further shifts in analyst consensus estimates to validate the sustained growth trajectory and to ascertain potential catalysts that could lead to a re-evaluation of its current 'Hold' status.